Global Coccidia Virus Live Vaccine Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Coccidia Virus Live Vaccine market size was valued at US$ 98 million in 2024 and is forecast to a readjusted size of USD 139 million by 2031 with a CAGR of 5.0% during review period.

The coccidia virus live vaccine is a vaccine used to prevent coccidiosis in poultry, such as chickens. Coccidiosis, caused by Eimeria spp., is a parasitic infection that primarily affects the intestines of poultry, leading to diarrhea, weight loss, and even death. This vaccine uses attenuated live coccidia viruses to simulate an infection, stimulating the immune system to produce antibodies and enhancing the poultry's immunity against future coccidia infections. Compared to traditional coccidiostat treatments, the vaccine not only helps reduce the development of drug resistance but also improves poultry production performance, such as weight gain in broilers and egg production in layers, promoting a more sustainable and environmentally friendly poultry industry.

This report is a detailed and comprehensive analysis for global Coccidia Virus Live Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Coccidia Virus Live Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Coccidia Virus Live Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Coccidia Virus Live Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Coccidia Virus Live Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Coccidia Virus Live Vaccine

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Coccidia Virus Live Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include MSD Animal Health, Boehringer Ingelheim, HIPRA, Bioproperties, Huvepharma, Nisseiken, Biopharm, Ceva Santé Animale, Vaxxinova, Foshan Standard Biotech, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Coccidia Virus Live Vaccine market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

Bivalent Vaccine

Trivalent Vaccine

Quadrivalent Vaccine

Market segment by Application

Poultry

Rabbit

Other

Major players covered

MSD Animal Health

Boehringer Ingelheim

HIPRA

Bioproperties

Huvepharma

Nisseiken

Biopharm

Ceva Santé Animale

Vaxxinova

Foshan Standard Biotech

Qilu Qingda Bio-Pharmaceutical

Skystar Bio-pharm

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Coccidia Virus Live Vaccine product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Coccidia Virus Live Vaccine, with price, sales quantity, revenue, and global market share of Coccidia Virus Live Vaccine from 2020 to 2025.

Chapter 3, the Coccidia Virus Live Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Coccidia Virus Live Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Coccidia Virus Live Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Coccidia Virus Live Vaccine.

Chapter 14 and 15, to describe Coccidia Virus Live Vaccine sales channel, distributors, customers, research findings and conclusion.